ORF57/MTA in KSHV Biology and Pathogenesis: Update From 2015
Journal of Medical Virology · 2026-06 · 98 (6)
DOI: 10.1002/jmv.70979 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, online erschienen am 29.05.2026. Verfasst von Zhi-Ming Zheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, National Institutes of …. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Gene Expression Regulation, Viral, Viral Regulatory and Accessory Proteins. Die Arbeit nennt 172 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIH Intramural Program.
Abstract (Originalsprache)
Kaposi's sarcoma‐associated herpesvirus (KSHV) ORF57, also known as MTA, is a viral nonstructural protein that belongs to a conserved family of functionally related proteins encoded by all herpesviruses. As an RNA‐binding protein, ORF57/MTA functions as a key post‐transcriptional regulator of viral gene expression and is essential for efficient viral replication and production of infectious virions. ORF57/MTA features two distinguishable domains: an intrinsic disordered N‐terminal domain or NTD for protein‐protein and protein‐RNA interactions and a structural α‐helix‐rich C‐terminal domain or CTD for ORF57/MTA dimerization to prevent its proteasome degradation. ORF57/MTA enhances viral gene expression by promoting RNA stability, RNA splicing, and translation of viral transcripts through its NTD domain in cooperation with host/viral cofactors as distinct individual ribonucleoprotein complexes. To mediate these diverse activities, ORF57/MTA binds MTA‐responsive elements (MREs) within target RNAs in a sequence and structural motif‐dependent manner. Most recent progresses in this update since 2015 include determination of ORF57/MTA domain structure and the crystal structure of its CTD, discovery of a novel role of ORF57/MTA in counteracting cellular innate immune responses through modulation of RNA granule biogenesis, genome‐wide identification of viral and host RNAs as ORF57/MTA targets, and elucidation of long‐distance viral RNA splicing crossing a large part of the KSHV genome. Collectively, these findings represent significant steps toward our understanding of ORF57/MTA‐mediated regulation of not only viral but also host gene expression, as exemplified by ORF57/MTA regulation of FOS expression. Nevertheless, many aspects of ORF57/MTA function remain to be determined and warrant future investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA.
ORCID-Profile: Zhi-Ming Zheng, Vladimir Majerciak
Förderung
- Intramural NIH HHS
- NIH Intramural Program
Zitieren
APA
Zheng, Z. M., & Majerciak, V. (2026). ORF57/MTA in KSHV Biology and Pathogenesis: Update From 2015. Journal of Medical Virology, 98(6). https://doi.org/10.1002/jmv.70979
Vancouver
Zheng ZM, Majerciak V. ORF57/MTA in KSHV Biology and Pathogenesis: Update From 2015. Journal of Medical Virology. 2026;98(6). doi:10.1002/jmv.70979
BibTeX
@article{Zheng2026,
author = {Zheng, Zhi-Ming and Majerciak, Vladimir},
title = {ORF57/MTA in KSHV Biology and Pathogenesis: Update From 2015},
journal = {Journal of Medical Virology},
year = {2026},
volume = {98},
number = {6},
doi = {10.1002/jmv.70979}
}
EUVIMED